Ronen Eavri

Ronen Eavri is an accomplished professional with extensive experience in the biotechnology and healthcare industries. Currently a member of 8400 - The Health Network since January 2020, Ronen has also served as CEO and co-founder of Barcode Nanotech since February 2017. Previous roles include staff scientist and preclinical lead at Johnson & Johnson, where responsibilities involved the development of FDA-approved products and leading exploratory concepts for various clinical indications. Ronen's early career includes work as a scientist at D Pharm LTD. and as a postdoctoral fellow at MIT, focusing on mechanisms for learning and memory. Additionally, Ronen has managerial experience with BioAbroad and has contributed as a marketing and scientific consultant with BioData. Educational qualifications include a Master of Business Administration from the Technion, a Ph.D. in Biochemistry from The Hebrew University of Jerusalem, and various degrees in biotechnology and life sciences.